SalioGen Therapeutics has launched Gene Coding, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA Integration Technology (EDITTM) platform. EDIT is based on the novel mammal-derived genomic engineering tool, for use in potentially curative genetic medicines.
Market
Inherited Diseases
Location
Cambridge,
MA,
USA
Coinvestors
Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity Management & Research Company, GordonMD Global Investments, PBM Capital Group, RD Fund, Symbiosis, T. Rowe Price Associates